| A Single Filing Reveals Elon Musk's Plan to Make Artificial Intelligence a "Winner Take All" Game, Says Top AI Expert James Altucher |
Globe Newswire |
09/08 |
07:15 |
| Generate Biomedicines Inc. to Participate in September Investor Conferences |
Globe Newswire |
09/08 |
07:09 |
| Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana |
Globe Newswire |
09/08 |
07:05 |
| Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event |
Globe Newswire |
09/08 |
07:05 |
| 4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics |
Globe Newswire |
09/08 |
07:05 |
| Microchip’s 1.2V Clock Buffers Link Latest SoCs and FPGAs with Higher Voltage Components |
Globe Newswire |
09/08 |
07:04 |
| 2026's elections could test how heavy trading on prediction markets affects races and results |
AP Online |
09/08 |
07:03 |
| IREN’s 2GW Sweetwater Hub Included as Base Load in ERCOT Batch Zero |
Globe Newswire |
09/08 |
07:01 |
| Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391) |
Globe Newswire |
09/08 |
07:00 |
| Lightbridge Letter to Shareholders Outlines Expedited Pathway to Bring Lightbridge Fuel™ to Commercial Reactors |
Globe Newswire |
09/08 |
07:00 |
| Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics |
Globe Newswire |
09/08 |
07:00 |
| Rigetti Signs Definitive Agreement for $100M with U.S. Government to Accelerate R&D for Superconducting Quantum Computing |
Globe Newswire |
09/08 |
07:00 |
| Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program |
Globe Newswire |
09/08 |
07:00 |
| Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis |
Globe Newswire |
09/08 |
07:00 |
| Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer |
Globe Newswire |
09/08 |
07:00 |
| NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor |
Globe Newswire |
09/08 |
07:00 |
| Lahontan Strengthens Technical, Engineering, and Business Development Team |
Globe Newswire |
09/08 |
07:00 |
| Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development |
Globe Newswire |
09/08 |
07:00 |
| G3 Goldfields Provides Update on Listing |
Globe Newswire |
09/08 |
07:00 |
| Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer |
Globe Newswire |
09/08 |
07:00 |
| Cloverleaf Bio Raises $33 Million Seed Financing to Advance Novel RNA-Based Cancer Therapeutics |
Globe Newswire |
09/08 |
07:00 |
| Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC |
Globe Newswire |
09/08 |
07:00 |
| Phoenix Metals Receives Amended Exploration Permit and Accelerates Phase 1 Drill Program at Greenwood |
Globe Newswire |
09/08 |
07:00 |
| OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference |
Globe Newswire |
09/08 |
07:00 |
| American Fusion Inc. (OTCQB: AMFN) Expands Intellectual Property Portfolio to 130 U.S. Patent Applications and Provides National Stock Exchange Uplisting and Capital Markets Update |
Globe Newswire |
09/08 |
07:00 |
